Rugge, M., M. Fassan, and D.Y. Graham, Epidemiology of gastric cancer, in Gastric Cancer. 2015, Springer. p. 23-34.
Fock KM, Ang TL. Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. J Gastroenterol Hepatol. 2010;25:479–486.
Baghestani AR, Daneshva T, Pourhoseingholi MA, Asadzadeh H. Survival of Colorectal Cancer in the Presence of Competing- Risks - Modeling by Weibull Distribution. Asian Pac J Cancer Prev 2016;17:1193-96.
Available from: http://globocan.iarc.fr/. Accessed September 20, 2013.
Mousavi, S.M., et al., Cancer incidence and mortality in Iran. Ann Oncol, 2009. 20(3): p.556-63.
American cancer society: Stomach Cancer. 2017; Available from: https://www.cancer.org/cancer/stomach-cancer.html.
Available from: https://www.cancer.net/cancer-types/stomach-cancer/statistics
Dai, J., et al., Gastrokine-2 is downregulated in gastric cancer and its restoration suppresses gastric tumorigenesis and cancer metastasis. Tumour Biol, 2014. 35(5): p. 4199-207.
Toback FG, Walsh-Reitz MM, Musch MW, Chang EB, Del Valle J, Ren H, et al. Peptide fragments of AMP-18, a novel secreted gastric antrum mucosal protein, are mitogenic and motogenic. Am J Physiol Gastrointest Liver Physiol. 2003;285:G344–G353.
Yoon JH, Seo HS, Choi SS, Chae HS, Choi WS, Kim O, et al. Gastrokine 1 inhibits the carcinogenic potentials of Helicobacter pylori CagA. Carcinogenesis. 2014 in press.
Yoon JH, Choi YJ, Choi WS, Nam SW, Lee JY, Park WS. Functional analysis of the NH2-terminal hydrophobic region and BRICHOS domain of GKN1. Biochem Biophys Res Commun. 2013;440:689–695.
Fahlbusch FB, Ruebner M, Huebner H, Volkert G, Bartunik H, Winterfeld I, Hartner A, Menendez-Castro C, Noegel SC, Marek I, Wachter D, Schneider-Stock R, Beckmann MW, Kehl S, Rascher W. Trophoblast expression dynamics of the tumor suppressor gene gastrokine 2. Histochem Cell Biol. 2015;144:281–291.
Moss SF, Lee JW, Sabo E, Rubin AK, Rommel J, Westley BR, May FE, Gao J, Meitner PA, Tavares R, Resnick MB. Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis. Clin Cancer Res. 2008;14:4161–4167.
Yoon, J.H., et al., Gastrokine 1 functions as a tumor suppressor by inhibition of epithelial-mesenchymal transition in gastric cancers. J Cancer Res Clin Oncol, 2011. 137(11): p. 1697-704
Norouzinia M, Asadzadeh H, Shalmani HM, Al Dulaimi D, Zali MR. Clinical and histological indicators of proximal and distal gastric cancer in eight provinces of Iran. Asian Pac J Cancer Prev 2012;13:5677-79.
Ichikawa T٫ Ishihara K. Protective Effects of Gastric Mucus, Dr. Paola Tonino٫ Gastritis and Gastric Cancer - New Insights in Gastroprotection, Diagnosis and Treatments. InTech/ 2011; 1-25.
Kim, O., et al., GKN2 contributes to the homeostasis of gastric mucosa by inhibiting GKN1 activity. J Cell Physiol, 2014. 229(6): p. 762-71.
Di Stadio, C.S., et al., Role of human GKN1 on APP processing in gastric cancer. Biochimie, 2017. 135: p. 149-153.
Yoon JH, Kang YH, Choi YJ, Park IS, Nam SW, Lee JY, Lee YS, Park WS. Gastrokine 1 functions as a tumor suppressor by inhibition of epithelial-mesenchymal transition in gastric cancers. J Cancer Res Clin Oncol. 2011; 137(11): 1697-704.
Mao W, Chen J, Peng TL, Yin XF, Chen LZ, Chen MH. Helicobacter pylori infection and administration of non-steroidal anti-inflammatory drugs down-regulate the expression of gastrokine-1 in gastric mucosa. Turk J Gastroenterol. 2012 ;23(3): 212-9.
Baus-Loncar, Mirela, et al. "Cytokine regulation of the trefoil factor family binding protein GKN2 (GDDR/TFIZ1/blottin) in human gastrointestinal epithelial cells." Cellular Physiology and Biochemistry 20.1-4 (2007): 193-204.
Hasan, A.A., et al., Down-Regulated Gene Expression of GKN1 and GKN2 as Diagnostic Markers for Gastric Cancer. International Scholarly and Scientific Research & Innovation, 2015. 9(6): p. 532-535.